We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
ICON plc, a global contract clinical research organisation, which has over 3,200 employees providing services to the pharmaceutical, biotech and medical device industries from 41 locations in 27 countries worldwide, today reported its financial results for the first quarter ended March 31, 2006.
Professor Ivan Addae-Mensah, a former Vice-Chancellor of the University of Ghana, has strongly recommended that the views of pharmacists should be sought and considered in taking decisions about drugs.
Evotec AG has announced that Sankyo has chosen Evotec as a partner to identify small molecule therapeutics for their pharmaceutical discovery projects.
U.S.-based drugmakers Alcon and Amgen have entered into a multitarget collaboration to jointly research, develop, and commercialize therapeutics for the treatment of eye diseases, the companies announced.
A post-exposure vaccine for Marburg virus that gave complete protection to experimental Rhesus macaques could be useful for humans as well, according to a study published in the British journal The Lancet.
Japan's Astellas Pharma and U.S.-based Ilypsa have entered into an agreement that gives Astellas exclusive rights to develop and market the hyperphosphatemia drug ILY101 in Japan.
Tripos, Inc., a leading provider of drug discovery chemistry and informatics products and services, today announced it will conduct a live audio webcast presentation and conference call to discuss quarterly financial results for the period ending March 31, 2006, at 10 a.m. EDT on Tuesday, May 9.